Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index: Figure 1.

Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer

(2014) Lori A Sturtz et al.   BMC CANCER

Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010–2011)

(2014) Helmneh M. Sineshaw et al.   BREAST CANCER RESEARCH AND TREATMENT

Interactions of Hormone Replacement Therapy, Body Weight, and Bilateral Oophorectomy in Breast Cancer Risk

(2014) Yong Cui et al.   CLINICAL CANCER RESEARCH

Prophylactic bilateral oophorectomy at time of hysterectomy for women at low risk: acog revises practice guidelines for ovarian cancer screening in low-risk women

(2014) C.A. Larson   Current Oncology

Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations

(2014) James H. Segars et al.   HUMAN REPRODUCTION UPDATE

Mammographic breast density in women with premature ovarian failure

(2014) Cristina Laguna Benetti-Pinto et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant

(2013) Ofure Obazee et al.   BREAST CANCER RESEARCH AND TREATMENT

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials

(2013) JoAnn E. Manson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast Density

(2013) Ningqi Hou et al.   JNCI-Journal of the National Cancer Institute

Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk

(2013) Catherine Méplan et al.   PLoS One

Racial/Ethnic Differences in Use and Duration of Adjuvant Hormonal Therapy for Breast Cancer in the Women's Health Initiative

(2012) J. C. Livaudais et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Changing Concepts: Menopausal Hormone Therapy and Breast Cancer

(2012) R. T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

(2012) Garnet L Anderson et al.   LANCET ONCOLOGY

Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer

(2012) Sophia Harlid et al.   BMC Womens Health

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

(2011) V. Beral et al.   JNCI-Journal of the National Cancer Institute

Association of the Joint Effect of Menopause and Hormone Replacement Therapy and Cancer in African American Women: The Jackson Heart Study

(2011) Brenda W. Campbell Jenkins et al.   International Journal of Environmental Research and Public Health

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

(2010) Rowan T. Chlebowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Influence of Socioeconomic Disparities on Breast Cancer Tumor Biology and Prognosis: A Review

(2009) Linda Vona-Davis et al.   JOURNAL OF WOMENS HEALTH